Serum Free Fatty Acids as Noninvasive Markers for Discriminating Early-Stage Oral Squamous Cell Carcinoma from Leukoplakia
Cancers · 18.11.2026 · 18 (22) · 3688
DOI: 10.3390/cancers18223688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.11.2026. Verfasst von Yosuke Fujii und 11 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Nihon University Research Grant-in-Aid for Donation Program, Nihon University Research Grant.
Abstract (Originalsprache)
Background/Objectives: Oral squamous cell carcinoma often arises from oral leukoplakia, a precancerous lesion. Distinguishing malignant transformation from leukoplakia currently relies on repeated, invasive biopsies. A noninvasive method to discriminate OSCC from leukoplakia is needed. Fatty acid metabolic reprogramming in cancers alters serum free fatty acid (FFA) profiles. We aimed to identify serum FFAs that distinguish OSCC from leukoplakia.
Methods
The gene expression of fatty acid metabolizing enzymes in leukoplakia and OSCC tissues was assessed using a public microarray dataset. Serum levels of 21 FFAs were quantified by liquid chromatography–tandem mass spectrometry in 68 healthy donors, 26 patients with leukoplakia, and 38 patients with OSCC.
Results
Fatty acid metabolizing enzyme genes were differentially expressed between leukoplakia and OSCC tissues, with upregulation of genes involved in de novo synthesis and downregulation of those involved in fatty acid uptake and lipolysis. Seven serum FFAs were significantly altered in OSCC from the early stage, whereas serum FFA levels in healthy donors were comparable to those in leukoplakia. Three of the altered FFAs—stearic acid, arachidic acid, and lauric acid—each discriminated OSCC from leukoplakia with high accuracy as single markers (area under the curve > 0.9), independently of clinical stage, age, and smoking history. Lauric acid was effective across the full clinical spectrum and the least affected by body composition, making it the most suitable for practical implementation.
Conclusions
Serum FFA profiling represents a promising noninvasive strategy for the early detection of OSCC, with the potential to complement biopsy in the surveillance of leukoplakia.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
- Nihon University Research Grant-in-Aid for Donation Program
- Nihon University Research Grant
Zitieren
APA
Fujii, Y., Katoh, Y., Ogawa, T., Fukuta, M., Otsuka, Y., Chang, E., Yamagata, K., Nishihara, A., Futatsugi, A., Sugawara, M., Kitano, H., & Hirai, S. (2026). Serum Free Fatty Acids as Noninvasive Markers for Discriminating Early-Stage Oral Squamous Cell Carcinoma from Leukoplakia. Cancers, 18(22), 3688. https://doi.org/10.3390/cancers18223688
Vancouver
Fujii Y, Katoh Y, Ogawa T, Fukuta M, Otsuka Y, Chang E, et al. Serum Free Fatty Acids as Noninvasive Markers for Discriminating Early-Stage Oral Squamous Cell Carcinoma from Leukoplakia. Cancers. 2026;18(22):3688. doi:10.3390/cancers18223688
BibTeX
@article{Fujii2026,
author = {Fujii, Yosuke and Katoh, Yuki and Ogawa, Tadashi and Fukuta, Mamiko and Otsuka, Yuichiro and Chang, Emily and Yamagata, Kanako and Nishihara, Anna and Futatsugi, Ayase and Sugawara, Masaki and Kitano, Hisataka and Hirai, Shuichi},
title = {Serum Free Fatty Acids as Noninvasive Markers for Discriminating Early-Stage Oral Squamous Cell Carcinoma from Leukoplakia},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3688},
doi = {10.3390/cancers18223688}
}
EUVIMED